38 related articles for article (PubMed ID: 29133279)
1. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
Cheng JN; Frye JB; Whitman SA; Ehsani S; Ali S; Funk JL
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38715255
[TBL] [Abstract][Full Text] [Related]
2. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.
Bandyopadhyay A; Wang L; Chin SH; Sun LZ
Neoplasia; 2007 Feb; 9(2):113-8. PubMed ID: 17356707
[TBL] [Abstract][Full Text] [Related]
4. PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destruction.
Tang L; Gao Y; Song Y; Li Y; Li Y; Zhang H; Li D; Li J; Liu C; Li F
Int J Biol Sci; 2020; 16(12):2235-2247. PubMed ID: 32549768
[TBL] [Abstract][Full Text] [Related]
5. The Role of ERα36 in Development and Tumor Malignancy.
Thiebaut C; Konan HP; Guerquin MJ; Chesnel A; Livera G; Le Romancer M; Dumond H
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526980
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents.
Sharma U; Marquis JC; Nicole Dinaut A; Hillier SM; Fedeles B; Rye PT; Essigmann JM; Croy RG
Bioorg Med Chem Lett; 2004 Jul; 14(14):3829-33. PubMed ID: 15203171
[TBL] [Abstract][Full Text] [Related]
7. Membrane estrogen receptors signal to determine transcription factor function.
Levin ER
Steroids; 2018 Apr; 132():1-4. PubMed ID: 29155215
[TBL] [Abstract][Full Text] [Related]
8. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
Maji S; Pradhan AK; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Windle JJ; Subler MA; Wang XY; Semmes OJ; Nyalwidhe JO; Mukhopadhyay N; Paul AK; Hatfield B; Levit MM; Madan E; Sarkar D; Emdad L; Cohen DJ; Gogna R; Cavenee WK; Das SK; Fisher PB
Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2307094120. PubMed ID: 37922327
[TBL] [Abstract][Full Text] [Related]
9. Osteolytic effects of tumoral estrogen signaling in an estrogen receptor-positive breast cancer bone metastasis model.
Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Brickey JA; Funk JL
J Cancer Metastasis Treat; 2021; 7():. PubMed ID: 34790880
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Investigations of miR-33a Expression in Estrogen Receptor-Targeting Therapies in Breast Cancer Cells.
Ozfiliz-Kilbas P; Sonmez O; Obakan-Yerlikaya P; Coker-Gurkan A; Palavan-Ünsal N; Uysal-Onganer P; Arisan ED
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771486
[TBL] [Abstract][Full Text] [Related]
11. Effect of 17β-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model.
Cohen DJ; Patel V; Verma A; Boyan BD; Schwartz Z
Steroids; 2019 Feb; 142():28-33. PubMed ID: 29133279
[TBL] [Abstract][Full Text] [Related]
12. Estradiol induces bone osteolysis in triple-negative breast cancer via its membrane-associated receptor ERα36.
Cohen DJ; Dennis CD; Deng J; Boyan BD; Schwartz Z
JBMR Plus; 2024 May; 8(5):ziae041. PubMed ID: 38644978
[TBL] [Abstract][Full Text] [Related]
13. Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo.
Winding B; Misander H; Høegh-Andersen P; Brünner N; Foged NT
Breast Cancer Res Treat; 2003 Mar; 78(2):205-16. PubMed ID: 12725420
[TBL] [Abstract][Full Text] [Related]
14. Skeletal impact of 17β-estradiol in T cell-deficient mice: age-dependent bone effects and osteosarcoma formation.
Cheng JN; Frye JB; Whitman SA; Funk JL
Clin Exp Metastasis; 2020 Apr; 37(2):269-281. PubMed ID: 31863240
[TBL] [Abstract][Full Text] [Related]
15. Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer.
Verma A; Schwartz N; Cohen DJ; Boyan BD; Schwartz Z
Steroids; 2019 Dec; 152():108498. PubMed ID: 31539535
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
